Shopping Cart 0
Cart Subtotal
AED 0

Sedia Biosciences Corp - Product Pipeline Analysis, 2019 Update

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 2753

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
AED 5505

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 8258
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

Sedia Biosciences Corp (SBC) is a medical device company that offers diagnostic products. The company provides medical devices, diagnostic devices, HIV incidence products, rapid point of care assays and specimen collection devices. It offers diagnostic products, epidemiological products, clinical products, rapid point of care diagnostic assays, novel epidemiological disease surveillance assays, monitoring devices and other public health tools. SBC provides services such as technology licensing, commercialization, medical device manufacturing and distributing, diagnostic testing, monitoring, white labeling, and technology transfer and development services. The company markets its products in the US and other European and Asian countries. SBC is headquartered in Portland, Oregon, the US.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

- The report analyzes all pipeline products in development for the company Sedia Biosciences Corp

- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

- The report provides detailed description of products in development, technical specification and functions

- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

- To formulate effective Research & Development strategies

- Develop market-entry and market expansion strategies

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents

List of Tables

List of Figures

Sedia Biosciences Corp Company Overview

Sedia Biosciences Corp Company Snapshot

Sedia Biosciences Corp Pipeline Products and Ongoing Clinical Trials Overview

Sedia Biosciences Corp-Pipeline Analysis Overview

Sedia Biosciences Corp-Key Facts

Sedia Biosciences Corp-Major Products and Services

Sedia Biosciences Corp Pipeline Products by Development Stage

Sedia Biosciences Corp Pipeline Products Overview

Asante Rapid Anti-Hepatitis B Ab Blood/Oral Fluid Test

Asante Rapid Anti-Hepatitis B Ab Blood/Oral Fluid Test Product Overview

Asante Rapid Hepatitis B sAg (Hepatitis B Surface Antigen) Blood/Oral Fluid Test

Asante Rapid Hepatitis B sAg (Hepatitis B Surface Antigen) Blood/Oral Fluid Test Product Overview

Asante Rapid Hepatitis C (Anti-Hepatitis C Antibody) Blood/Oral Fluid Test

Asante Rapid Hepatitis C (Anti-Hepatitis C Antibody) Blood/Oral Fluid Test Product Overview

Asante Rapid HIV-1 Recency (or Incidence) Assay

Asante Rapid HIV-1 Recency (or Incidence) Assay Product Overview

Asante Rapid Syphilis Oral Fluid Test

Asante Rapid Syphilis Oral Fluid Test Product Overview

Rapid Oral Fluid HIV Test

Rapid Oral Fluid HIV Test Product Overview

Sedia Biosciences Corp-Key Competitors

Sedia Biosciences Corp-Key Employees

Sedia Biosciences Corp-Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Recent Developments

Sedia Biosciences Corp, Recent Developments

Aug 30, 2016: Sedia Biosciences Awarded Additional USD 1.8 M NIH Grant for Novel Rapid HIV Test for Recent Infections

Sep 21, 2015: Sedia Biosciences Expands Its HIV-1 LAg-Avidity Assay for Recent HIV-1 Infections to Dried Blood Spot Specimens

Oct 23, 2014: Independent Study Shows Sedia's New HIV-1 LAg-Avidity Test is Top Performing Incidence Assay

Aug 18, 2014: NIH Awards Sedia Biosciences USD 195,490 SBIR Grant for Rapid HIV-1 Incidence Assay

Aug 13, 2014: Sedia Biosciences Launches Asante DNA, A New DNA Specimen Collection Kit

Feb 12, 2014: Sedia Biosciences Receives USD 1.0 Million NIH Grant for New HIV Diagnostic Assay

Appendix

Methodology

About GlobalData

Contact Us

Disclaimer


List Of Figure

List of Figures

Sedia Biosciences Corp Pipeline Products by Equipment Type

Sedia Biosciences Corp Pipeline Products by Development Stage


List Of Table

List of Tables

Sedia Biosciences Corp Pipeline Products and Ongoing Clinical Trials Overview

Sedia Biosciences Corp Pipeline Products by Equipment Type

Sedia Biosciences Corp Pipeline Products by Indication

Sedia Biosciences Corp, Key Facts

Sedia Biosciences Corp, Major Products and Services

Sedia Biosciences Corp Number of Pipeline Products by Development Stage

Sedia Biosciences Corp Pipeline Products Summary by Development Stage

Asante Rapid Anti-Hepatitis B Ab Blood/Oral Fluid Test-Product Status

Asante Rapid Anti-Hepatitis B Ab Blood/Oral Fluid Test-Product Description

Asante Rapid Hepatitis B sAg (Hepatitis B Surface Antigen) Blood/Oral Fluid Test-Product Status

Asante Rapid Hepatitis B sAg (Hepatitis B Surface Antigen) Blood/Oral Fluid Test-Product Description

Asante Rapid Hepatitis C (Anti-Hepatitis C Antibody) Blood/Oral Fluid Test-Product Status

Asante Rapid Hepatitis C (Anti-Hepatitis C Antibody) Blood/Oral Fluid Test-Product Description

Asante Rapid HIV-1 Recency (or Incidence) Assay-Product Status

Asante Rapid HIV-1 Recency (or Incidence) Assay-Product Description

Asante Rapid Syphilis Oral Fluid Test-Product Status

Asante Rapid Syphilis Oral Fluid Test-Product Description

Rapid Oral Fluid HIV Test-Product Status

Rapid Oral Fluid HIV Test-Product Description

Sedia Biosciences Corp, Key Employees

Sedia Biosciences Corp, Subsidiaries

Glossary

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Sedia Biosciences Corp, Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies


Companies

Sekisui Diagnostics LLC

LEAP Biosciences Corp

ISK Biosciences Corporation

InQ Biosciences Corporation

Helicos BioSciences Corporation

AxCell Biosciences Corp

Summary

Sedia Biosciences Corp (SBC) is a medical device company that offers diagnostic products. The company provides medical devices, diagnostic devices, HIV incidence products, rapid point of care assays and specimen collection devices. It offers diagnostic products, epidemiological products, clinical products, rapid point of care diagnostic assays, novel epidemiological disease surveillance assays, monitoring devices and other public health tools. SBC provides services such as technology licensing, commercialization, medical device manufacturing and distributing, diagnostic testing, monitoring, white labeling, and technology transfer and development services. The company markets its products in the US and other European and Asian countries. SBC is headquartered in Portland, Oregon, the US.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

- The report analyzes all pipeline products in development for the company Sedia Biosciences Corp

- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

- The report provides detailed description of products in development, technical specification and functions

- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

- To formulate effective Research & Development strategies

- Develop market-entry and market expansion strategies

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Scope

Table of Contents

Table of Contents

List of Tables

List of Figures

Sedia Biosciences Corp Company Overview

Sedia Biosciences Corp Company Snapshot

Sedia Biosciences Corp Pipeline Products and Ongoing Clinical Trials Overview

Sedia Biosciences Corp-Pipeline Analysis Overview

Sedia Biosciences Corp-Key Facts

Sedia Biosciences Corp-Major Products and Services

Sedia Biosciences Corp Pipeline Products by Development Stage

Sedia Biosciences Corp Pipeline Products Overview

Asante Rapid Anti-Hepatitis B Ab Blood/Oral Fluid Test

Asante Rapid Anti-Hepatitis B Ab Blood/Oral Fluid Test Product Overview

Asante Rapid Hepatitis B sAg (Hepatitis B Surface Antigen) Blood/Oral Fluid Test

Asante Rapid Hepatitis B sAg (Hepatitis B Surface Antigen) Blood/Oral Fluid Test Product Overview

Asante Rapid Hepatitis C (Anti-Hepatitis C Antibody) Blood/Oral Fluid Test

Asante Rapid Hepatitis C (Anti-Hepatitis C Antibody) Blood/Oral Fluid Test Product Overview

Asante Rapid HIV-1 Recency (or Incidence) Assay

Asante Rapid HIV-1 Recency (or Incidence) Assay Product Overview

Asante Rapid Syphilis Oral Fluid Test

Asante Rapid Syphilis Oral Fluid Test Product Overview

Rapid Oral Fluid HIV Test

Rapid Oral Fluid HIV Test Product Overview

Sedia Biosciences Corp-Key Competitors

Sedia Biosciences Corp-Key Employees

Sedia Biosciences Corp-Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Recent Developments

Sedia Biosciences Corp, Recent Developments

Aug 30, 2016: Sedia Biosciences Awarded Additional USD 1.8 M NIH Grant for Novel Rapid HIV Test for Recent Infections

Sep 21, 2015: Sedia Biosciences Expands Its HIV-1 LAg-Avidity Assay for Recent HIV-1 Infections to Dried Blood Spot Specimens

Oct 23, 2014: Independent Study Shows Sedia's New HIV-1 LAg-Avidity Test is Top Performing Incidence Assay

Aug 18, 2014: NIH Awards Sedia Biosciences USD 195,490 SBIR Grant for Rapid HIV-1 Incidence Assay

Aug 13, 2014: Sedia Biosciences Launches Asante DNA, A New DNA Specimen Collection Kit

Feb 12, 2014: Sedia Biosciences Receives USD 1.0 Million NIH Grant for New HIV Diagnostic Assay

Appendix

Methodology

About GlobalData

Contact Us

Disclaimer


List Of Figure

List of Figures

Sedia Biosciences Corp Pipeline Products by Equipment Type

Sedia Biosciences Corp Pipeline Products by Development Stage


List Of Table

List of Tables

Sedia Biosciences Corp Pipeline Products and Ongoing Clinical Trials Overview

Sedia Biosciences Corp Pipeline Products by Equipment Type

Sedia Biosciences Corp Pipeline Products by Indication

Sedia Biosciences Corp, Key Facts

Sedia Biosciences Corp, Major Products and Services

Sedia Biosciences Corp Number of Pipeline Products by Development Stage

Sedia Biosciences Corp Pipeline Products Summary by Development Stage

Asante Rapid Anti-Hepatitis B Ab Blood/Oral Fluid Test-Product Status

Asante Rapid Anti-Hepatitis B Ab Blood/Oral Fluid Test-Product Description

Asante Rapid Hepatitis B sAg (Hepatitis B Surface Antigen) Blood/Oral Fluid Test-Product Status

Asante Rapid Hepatitis B sAg (Hepatitis B Surface Antigen) Blood/Oral Fluid Test-Product Description

Asante Rapid Hepatitis C (Anti-Hepatitis C Antibody) Blood/Oral Fluid Test-Product Status

Asante Rapid Hepatitis C (Anti-Hepatitis C Antibody) Blood/Oral Fluid Test-Product Description

Asante Rapid HIV-1 Recency (or Incidence) Assay-Product Status

Asante Rapid HIV-1 Recency (or Incidence) Assay-Product Description

Asante Rapid Syphilis Oral Fluid Test-Product Status

Asante Rapid Syphilis Oral Fluid Test-Product Description

Rapid Oral Fluid HIV Test-Product Status

Rapid Oral Fluid HIV Test-Product Description

Sedia Biosciences Corp, Key Employees

Sedia Biosciences Corp, Subsidiaries

Glossary

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products

Sedia Biosciences Corp, Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies


Companies

Sekisui Diagnostics LLC

LEAP Biosciences Corp

ISK Biosciences Corporation

InQ Biosciences Corporation

Helicos BioSciences Corporation

AxCell Biosciences Corp

chat_bubbleLet's Chat